The SIDP Podcast
Breakpoints
Claim This Podcastby Society of Infectious Diseases Pharmacists
4.9(233 reviews)
135 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
69
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality81
Social94
YouTube0
Engagement95
Podcast Overview
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
69
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality81
Social94
YouTube0
Engagement95
7
Excellent Areas
3
Good Performance
9
Growth Opportunities
excellent
Episode Length
1h 7m
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
needs improvement
Publishing Consistency
Every 19 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Breakpoints
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 22, 2026
#135 – Stewie Struggles: Small Hospital Edition
Dr. Whitney Buckel interviews Dr. Tina Khadem and Dr. Ashley Cubillos about antimicrobial stewardship strategies for small hospitals.
May 8, 2026
#134 – ESCMID Global Trials: PETER PEN and ASTARTE
<p>Professor Mical Paul and Professor Jesús Rodríguez-Baño join Professor Josh Davis and Dr Erin McCreary for a special Breakpoints and Communicable podcast collaboration. This episode discusses the ‘Trials Run’ session at ESCMID Global, where two randomized, clinical trials are presented in great depth. This year, both trials focused on treatment of cephalosporin-resistant Enterobacterales bacteremia. Listen to the authors describe why they performed these trials, results, and implications for clinical practice.</p> <p>References:</p> <p>1. Paul, M., & Rodríguez-Baño, J. (2026, April 20). The trial run: treatment of ESBL bacteraemia[LW1] - off to never-never land. [Presentation]. ESCMID Global 2026, Munich, Germany. <a href="https://www.google.com/url?sa=i\&source=web\&rct=j\&url=https://www.escmid.org/congress-events/escmid-global/\&ved=2ahUKEwilq56d15-UAxVukYkEHValMGAQy_kOegYIAQgHEAE\&opi=89978449\&cd\&psig=AOvVaw2h4KK1dj0m0Zs4RvVuGxK3\&ust=1777985757651000" rel="nofollow">ESCMID Global Virtual Platform</a>.</p> <p>2. Bitterman R, Koppel F, Mussini C, et al. Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen). BMJ Open. 2021;11(2):e040210. Published 2021 Feb 8. doi:10.1136/bmjopen-2020-040210</p> <p>3. Marín-Candón A, Rosso-Fernández CM, Bustos de Godoy N, et al. Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial [Internet]. BMJ Open. 2021 Sep 27;11(9):e049481. Available from: <a href="http://bmj.com" rel="nofollow">bmj.com</a> doi: 10.1136/bmjopen-2021-049481</p> <p>Learn more about the Society of Infectious Diseases Pharmacists: <a href="https://protect2.fireeye.com/v1/url?k=4063f96c-1ff8c1be-4063b7ad-867b1e11f55a-4ebd02e8eaa2fcc2\&q=1\&e=caf63b63-0143-4fa9-a81b-8d3031af3116\&u=https%3A%2F%2Fsidp.org%2FAbout" rel="nofollow">https://sidp.org/About</a></p> <p>Instagram: @SIDPharm (<a href="https://www.instagram.com/sidpharm/" rel="nofollow">https://www.instagram.com/sidpharm/</a>) or @breakpointspodcast_sidp (<a href="https://www.instagram.com/breakpointspodcast_sidp/" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/</a>)<a href="https://www.instagram.com/breakpointspodcast_sidp/?hl=en" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/?hl=en</a></p> <p>Facebook: <a href="https://protect2.fireeye.com/v1/url?k=55e28658-0a79be8a-55e2c899-867b1e11f55a-8b838b5b24786aee\&q=1\&e=caf63b63-0143-4fa9-a81b-8d3031af3116\&u=https%3A%2F%2Fwww.facebook.com%2Fsidprx" rel="nofollow">https://www.facebook.com/sidprx</a></p> <p>LinkedIn: <a href="https://www.linkedin.com/company/sidp/" rel="nofollow">https://www.linkedin.com/company/sidp/</a></p> <p>SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: <a href="https://sidp.org/Become-a-Member" rel="nofollow">https://sidp.org/Become-a-Member</a></p> <p>Listen to Breakpoints on <a href="https://clicktime.symantec.com/3R8uEM1294vdh21uL7nDhi37VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DD0L0Q0-2A2f7TCFxVOgWn67jW1UJdXCNI8Kg8JiVOalanWSnv86s3-2A2feIgSCp0yFQqON7208n7OVg3dZANuq14i1FyBxNlUE-2A2fEuorj-2A2bQth-2A2f-2A2fdOz0-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJP8qJ0DM-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnaJ94CqlnGko8PYcHx7P0a2ORkqJjTTXTXo3of9toOI%26e%3D" rel="nofollow">iTunes</a>, <a href="https://clicktime.symantec.com/3UPSKiX9zWTmFRi5JvbYYuF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DuVw7WrCV3UsT9jQEoMx19bCJk8wSnOrHKsz-2A2fiDg5jIJz-2A2fPmlAAnjeQMczcZNKe65FwcZB1GSntOoUYpImtNgtdyfUUiYEctoWEc5okmtqjI-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJSsDRBjw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DiSHbkOT6yU9AfKVXVzZYoT6ihqn4rV7u2MtsJu0S4M0%26e%3D" rel="nofollow">Overcast</a>, <a href="https://clicktime.symantec.com/3PoPyJU9wVY1CeG5JSoJ5TF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3D-2A2b6F4mrvzRMOPk-2A2ba-2A2bOlEsgbBTfXcxd55wOs9FeTrvlo4ldPpqgt3wD8-2A2fE3HTFftwPVPPM-2A2b6cPP8AXhMlUJL-2A2fVJcCllOYuUjVjRDDAWZ7AIEA-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJznOuBy8-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D2k6k5CxoFMUsUIyOPzQO6SsDBdBx1NhRPK1AYDToK7g%26e%3D" rel="nofollow">Spotify</a>, <a href="https://clicktime.symantec.com/3EzDPdcsg2aGkG24TqSDnQD7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DSMv1IUOMa6BBtA9x3UJdt0xL08TAUa63rcUQgIHTRk5z0skO9IEnaSqnkGdDVELU4LHF4xYo6n4QprSv5REh8CiWi24tVPHxui-2A2fuqe-2A2bSTcY-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgDogjBg-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dg4LAADo6MhO--d9qoDcdunhQOKfhr7JZ5QH6liBGX1w%26e%3D" rel="nofollow">Listen Notes</a>, <a href="https://clicktime.symantec.com/3K5DQtmVxCMwmFfYTXFqors7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DVTJG9hRIZySdc5y4-2A2bhe4mxglJA6g9BcwePDuINOrGkp6xW-2A2brG3A2kq5lxBfriwS6WTOLOSeS4ISBSaSBKW5soT53zrLCvjBMOj4J11xQuOQ-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgJndlwc-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D8zQ_WQmmq_ADO_yxCG2pCmfPHOXyBOt3Tvd8SLzw0ZM%26e%3D" rel="nofollow">Player FM</a>, <a href="https://clicktime.symantec.com/3WCdXn4P2EkTbSZz3j2efpW7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DRuxN50dhXQmkw9mJ-2A2fIv1BwOldEM8lu6wJn-2A2bp-2A2bFH1TNKc-2A2fH8BYSR8y8gvYx02jfY5q57aOItrIB31hBXqNyioCeEXlh0uZxM-2A2b7yda7rBp-2A2bnQ-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJdwUkjek-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dph48oB1hX73YsIdjGLx2gcMvE6IA7KTEWazW2Gb_tGg%26e%3D" rel="nofollow">Pocket Casts</a>, <a href="https://clicktime.symantec.com/3N9YYH2wFKdrWqgcDLyAPVP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DbAcy2XwOPS5gzW3aqAHBDq3X-2A2fsXg3wyMXKklW6Ulzx0aRoyw2zdXn6m5fVIKUO608flwXYyAGXiN4hWz7mMsGMCS55chZ6PJz8V8gIyX8HI-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgEBT6ts-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DPqs1eg6C2SkR8SgsjTAKF3jDx-0k2raeM9htByu_Ghs%26e%3D" rel="nofollow">Stitcher</a>, <a href="https://clicktime.symantec.com/3QxZKFTBT9VdfKHPUjpQykP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DXRXFG9Dw8bLzFpLbMrEfM96UuBur0JW9QvgSd3FZ4RzNUy-2A2bAuHT4n48P5fT3624i4mKWOBMJ2c6glolIQP9Z0iI7LjIz87QyZ5cKKJCKaNc-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJErop2PU-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DM0gZOkT6pxtYnqMcQRd_VtlxUl-5PqROGqAmvy3qmMc%26e%3D" rel="nofollow">Google Play</a>, <a href="https://clicktime.symantec.com/3HAZ1dAKjokvr2fVP1FEFmZ7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DHM5q-2A2bqjVNHXHSuzhQfgDHnfYMTayJY5I54xK583XQlZuSY-2A2fiukAdy7bGkpDwwp4DsXAS8nTuZi2kow5ilRLCsjmfJitQC61ab1gmhUelJY4-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJpiKf8vY-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dl98Xj6atbJE3Bl9nQFR0NxeCSObWEBXn2QRprS9VAPM%26e%3D" rel="nofollow">TuneIn</a>, <a href="https://clicktime.symantec.com/3Uc5sj35HuHzBtN9qsZELaz7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DGDsckAp3VJZvS-2A2b-2A2bFQBnNnris8ulgVAn4tAgxp4bAnDy-2A2bDLqT7z-2A2btergfEsE7sz7-2A2fi9-2A2bFF54K4LSozTCeCmh8VOosKkqijPiN5VAKc79XwEk-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJoMTwltw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DOqwdj1qqIUl3AHO7g0LP6TxXzSXeXUX4Ce_Sv_hRfyw%26e%3D" rel="nofollow">Blubrry</a>, <a href="https://clicktime.symantec.com/3Dfmv5CECYNRhGAwqZ5sQdY7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DQ7W-2A2bjxudl-2A2biTqflXrhVsrXi0r-2A2fptIhwKQytXBX17a9V2Op9GnTA1RTRGL19e54xgVdZSW-2A2bJeLiR7wWXkwDiSYgglUPHsNsGqAu6xuhXPp6o-2A3d-5F-5F-3BJSUlJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJzCo9rGw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnBRVi03Hc0KelEEqohO2GHfC96p04Pkm8F2eHsswsZY%26e%3D" rel="nofollow">RadioPublic</a>, or by using our RSS feed: <a href="https://sidp.pinecast.co/" rel="nofollow">https://sidp.pinecast.co/</a></p>
April 17, 2026
#133 – Trash talk: Earth Day Special on Healthcare Sustainability and Stewardship
<p>Climate change in the context of healthcare can feel overwhelming but it doesn’t have to be paralyzing. We’re diving into the intersection of climate change and antimicrobial resistance with a focus on practical, actionable steps healthcare organizations can take. Drs. Shreya Doshi, Andrea Pallotta and Preeti Jaggi join Dr. Whitney Buckel to talk about what’s real, what matters for healthcare, and where stewardship teams can make a meaningful impact.</p> <p>References:</p> <p>1. Sustainabil‑ID. <a href="https://sustainabil-id.com/" rel="nofollow">https://sustainabil-id.com/</a></p> <p>2. National Academy of Medicine. Climate Collaborative.https://<a href="http://nam.edu/our-work/programs/climate-and-health/climate-collaborative/" rel="nofollow">nam.edu/our-work/programs/climate-and-health/climate-collaborative/</a></p> <p>3. Medicine for a Changing Planet. <a href="https://www.medicineforachangingplanet.org" rel="nofollow">https://www.medicineforachangingplanet.org</a></p> <p>4. Cascades Canada. <a href="https://cascadescanada.ca/" rel="nofollow">https://cascadescanada.ca/</a></p> <p>5. EcoRxChoice. <a href="https://ecorxchoice.com" rel="nofollow">https://ecorxchoice.com</a></p> <p>6. Rx for Climate. <a href="https://www.rxforclimate.org/" rel="nofollow">https://www.rxforclimate.org/</a></p> <p>7. Practice Greenhealth. <a href="https://practicegreenhealth.org" rel="nofollow">https://practicegreenhealth.org</a></p> <p>8. Healthcare Without Harm. <a href="https://healthcarewithoutharm.org" rel="nofollow">https://healthcarewithoutharm.org</a></p> <p>9. Healthcare Sustainability and Infectious Diseases. _J Pediatric Infect Dis Soc._https://<a href="http://academic.oup.com/jpids/pages/healthcare-sustainability-and-infectious-diseases" rel="nofollow">academic.oup.com/jpids/pages/healthcare-sustainability-and-infectious-diseases</a></p> <p>10. PubMed. PMID: 40434281. <a href="https://pubmed.ncbi.nlm.nih.gov/40434281/" rel="nofollow">https://pubmed.ncbi.nlm.nih.gov/40434281/</a></p> <p>11. PubMed Central. PMC12616928. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12616928/" rel="nofollow">https://pmc.ncbi.nlm.nih.gov/articles/PMC12616928/</a></p> <p>12. Sustainable Healthcare Networks. Scale and spread quality improvement initiative promoting metronidazole IV‑to‑oral switch.https://<a href="http://networks.sustainablehealthcare.org.uk/resources/scale-and-spread-quality-improvement-initiative-promoting-metronidazole-iv-oral-switch-" rel="nofollow">networks.sustainablehealthcare.org.uk/resources/scale-and-spread-quality-improvement-initiative-promoting-metronidazole-iv-oral-switch-</a></p> <p>Learn more about the Society of Infectious Diseases Pharmacists: <a href="https://protect2.fireeye.com/v1/url?k=4063f96c-1ff8c1be-4063b7ad-867b1e11f55a-4ebd02e8eaa2fcc2\&q=1\&e=caf63b63-0143-4fa9-a81b-8d3031af3116\&u=https%3A%2F%2Fsidp.org%2FAbout" rel="nofollow">https://sidp.org/About</a></p> <p>Instagram: @SIDPharm (<a href="https://www.instagram.com/sidpharm/" rel="nofollow">https://www.instagram.com/sidpharm/</a>) or @breakpointspodcast_sidp (<a href="https://www.instagram.com/breakpointspodcast_sidp/" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/</a>)<a href="https://www.instagram.com/breakpointspodcast_sidp/?hl=en" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/?hl=en</a></p> <p>Facebook: <a href="https://protect2.fireeye.com/v1/url?k=55e28658-0a79be8a-55e2c899-867b1e11f55a-8b838b5b24786aee\&q=1\&e=caf63b63-0143-4fa9-a81b-8d3031af3116\&u=https%3A%2F%2Fwww.facebook.com%2Fsidprx" rel="nofollow">https://www.facebook.com/sidprx</a></p> <p>LinkedIn: <a href="https://www.linkedin.com/company/sidp/" rel="nofollow">https://www.linkedin.com/company/sidp/</a></p> <p>SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: <a href="https://sidp.org/Become-a-Member" rel="nofollow">https://sidp.org/Become-a-Member</a></p> <p>Listen to Breakpoints on <a href="https://clicktime.symantec.com/3R8uEM1294vdh21uL7nDhi37VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DD0L0Q0-2A2f7TCFxVOgWn67jW1UJdXCNI8Kg8JiVOalanWSnv86s3-2A2feIgSCp0yFQqON7208n7OVg3dZANuq14i1FyBxNlUE-2A2fEuorj-2A2bQth-2A2f-2A2fdOz0-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJP8qJ0DM-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnaJ94CqlnGko8PYcHx7P0a2ORkqJjTTXTXo3of9toOI%26e%3D" rel="nofollow">iTunes</a>, <a href="https://clicktime.symantec.com/3UPSKiX9zWTmFRi5JvbYYuF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DuVw7WrCV3UsT9jQEoMx19bCJk8wSnOrHKsz-2A2fiDg5jIJz-2A2fPmlAAnjeQMczcZNKe65FwcZB1GSntOoUYpImtNgtdyfUUiYEctoWEc5okmtqjI-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJSsDRBjw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DiSHbkOT6yU9AfKVXVzZYoT6ihqn4rV7u2MtsJu0S4M0%26e%3D" rel="nofollow">Overcast</a>, <a href="https://clicktime.symantec.com/3PoPyJU9wVY1CeG5JSoJ5TF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3D-2A2b6F4mrvzRMOPk-2A2ba-2A2bOlEsgbBTfXcxd55wOs9FeTrvlo4ldPpqgt3wD8-2A2fE3HTFftwPVPPM-2A2b6cPP8AXhMlUJL-2A2fVJcCllOYuUjVjRDDAWZ7AIEA-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJznOuBy8-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D2k6k5CxoFMUsUIyOPzQO6SsDBdBx1NhRPK1AYDToK7g%26e%3D" rel="nofollow">Spotify</a>, <a href="https://clicktime.symantec.com/3EzDPdcsg2aGkG24TqSDnQD7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DSMv1IUOMa6BBtA9x3UJdt0xL08TAUa63rcUQgIHTRk5z0skO9IEnaSqnkGdDVELU4LHF4xYo6n4QprSv5REh8CiWi24tVPHxui-2A2fuqe-2A2bSTcY-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgDogjBg-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dg4LAADo6MhO--d9qoDcdunhQOKfhr7JZ5QH6liBGX1w%26e%3D" rel="nofollow">Listen Notes</a>, <a href="https://clicktime.symantec.com/3K5DQtmVxCMwmFfYTXFqors7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DVTJG9hRIZySdc5y4-2A2bhe4mxglJA6g9BcwePDuINOrGkp6xW-2A2brG3A2kq5lxBfriwS6WTOLOSeS4ISBSaSBKW5soT53zrLCvjBMOj4J11xQuOQ-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgJndlwc-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D8zQ_WQmmq_ADO_yxCG2pCmfPHOXyBOt3Tvd8SLzw0ZM%26e%3D" rel="nofollow">Player FM</a>, <a href="https://clicktime.symantec.com/3WCdXn4P2EkTbSZz3j2efpW7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DRuxN50dhXQmkw9mJ-2A2fIv1BwOldEM8lu6wJn-2A2bp-2A2bFH1TNKc-2A2fH8BYSR8y8gvYx02jfY5q57aOItrIB31hBXqNyioCeEXlh0uZxM-2A2b7yda7rBp-2A2bnQ-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJdwUkjek-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dph48oB1hX73YsIdjGLx2gcMvE6IA7KTEWazW2Gb_tGg%26e%3D" rel="nofollow">Pocket Casts</a>, <a href="https://clicktime.symantec.com/3N9YYH2wFKdrWqgcDLyAPVP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DbAcy2XwOPS5gzW3aqAHBDq3X-2A2fsXg3wyMXKklW6Ulzx0aRoyw2zdXn6m5fVIKUO608flwXYyAGXiN4hWz7mMsGMCS55chZ6PJz8V8gIyX8HI-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgEBT6ts-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DPqs1eg6C2SkR8SgsjTAKF3jDx-0k2raeM9htByu_Ghs%26e%3D" rel="nofollow">Stitcher</a>, <a href="https://clicktime.symantec.com/3QxZKFTBT9VdfKHPUjpQykP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DXRXFG9Dw8bLzFpLbMrEfM96UuBur0JW9QvgSd3FZ4RzNUy-2A2bAuHT4n48P5fT3624i4mKWOBMJ2c6glolIQP9Z0iI7LjIz87QyZ5cKKJCKaNc-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJErop2PU-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DM0gZOkT6pxtYnqMcQRd_VtlxUl-5PqROGqAmvy3qmMc%26e%3D" rel="nofollow">Google Play</a>, <a href="https://clicktime.symantec.com/3HAZ1dAKjokvr2fVP1FEFmZ7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DHM5q-2A2bqjVNHXHSuzhQfgDHnfYMTayJY5I54xK583XQlZuSY-2A2fiukAdy7bGkpDwwp4DsXAS8nTuZi2kow5ilRLCsjmfJitQC61ab1gmhUelJY4-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJpiKf8vY-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dl98Xj6atbJE3Bl9nQFR0NxeCSObWEBXn2QRprS9VAPM%26e%3D" rel="nofollow">TuneIn</a>, <a href="https://clicktime.symantec.com/3Uc5sj35HuHzBtN9qsZELaz7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DGDsckAp3VJZvS-2A2b-2A2bFQBnNnris8ulgVAn4tAgxp4bAnDy-2A2bDLqT7z-2A2btergfEsE7sz7-2A2fi9-2A2bFF54K4LSozTCeCmh8VOosKkqijPiN5VAKc79XwEk-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJoMTwltw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DOqwdj1qqIUl3AHO7g0LP6TxXzSXeXUX4Ce_Sv_hRfyw%26e%3D" rel="nofollow">Blubrry</a>, <a href="https://clicktime.symantec.com/3Dfmv5CECYNRhGAwqZ5sQdY7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DQ7W-2A2bjxudl-2A2biTqflXrhVsrXi0r-2A2fptIhwKQytXBX17a9V2Op9GnTA1RTRGL19e54xgVdZSW-2A2bJeLiR7wWXkwDiSYgglUPHsNsGqAu6xuhXPp6o-2A3d-5F-5F-3BJSUlJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJzCo9rGw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnBRVi03Hc0KelEEqohO2GHfC96p04Pkm8F2eHsswsZY%26e%3D" rel="nofollow">RadioPublic</a>, or by using our RSS feed: <a href="https://sidp.pinecast.co/" rel="nofollow">https://sidp.pinecast.co/</a></p>
135 total episodes available with 21 transcripts
Recent guests on Breakpoints
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Tina Khadem
Guest
Ashley Cubillos
Guest
Dana Bowers
Guest
Kyle Molina
Guest
Pranita Tamma
Guest
Benedikt Huttner
Guest
Dr Ted Morton
Guest
Dr Christine Lockowitz
Guest
Zahra Kassamali Escobar
Guest
Jamie Wagner
Guest
Amy Crockett
Guest
Ben Ereshefsky
Guest
Similar Podcasts
Discover related shows you might enjoy
Infectious Disease Puscast
Vincent Racaniello
Febrile
Sara Dong
Communicable
CMI Communications
ID:IOTS - Infectious Disease Insight Of Two Specialists
Infectious Disease: Insights of Two Specialists
Core IM | Internal Medicine Podcast
Core IM Team
The Clinical Problem Solvers
The Clinical Problem Solvers
Annals On Call Podcast
American College of Physicians
JAMA Clinical Reviews
JAMA Network
Let's Talk ID
Infectious Diseases Society of America (IDSA)
The Curious Clinicians
The Curious Clinicians
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
Harrison's PodClass: Internal Medicine Cases and Board Prep
AccessMedicine
Critical Care Time
Critical Care Time Podcast
Cardionerds: A Cardiology Podcast
CardioNerds
This Week in Virology
Vincent Racaniello
Deep-dive analytics for Breakpoints
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Breakpoints?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.